New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...
Roche targets more than $3 billion in annual obesity sales
Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...
Roche sees Carmot obesity drugs' potential peak sales at $3.6B+: report
Roche (OTCQX:RHHBY) said Monday that three obesity and diabetes drug candidates acquired through its takeover of Carmot ...
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
At its Pharma Day, Swiss pharmaceutical giant Roche Holdings AG (OTC:RHHBY) outlined five priority therapeutic areas: ...
This fund manager's secrets can help you find the market's best stocks
A portfolio holding that checks all these boxes is analog chip maker Texas Instruments (TXN). The company invests to build out its own manufacturing capacity, which helps make it a low-cost supplier.
Chemotherapy can be a challenging treatment – here’s how to deal with some of the side ...
Common issues such as hair loss, nausea, skin problems and fatigue can seriously affect patients’ quality of life.
Drug Store News54 分钟
9amHealth, Instacart partner to help employers expand access to healthy foods
The companies report early success, with a 161% increase in member enrollment and a 57% boost in engagement in programs that ...
gna13 分钟
GOSANET Foundation begins free TB screening in Adaklu district
GOSANET Foundation, a health NGO operating in the Adaklu district commenced a free community-based tuberculosis (TB) case ...